In 1981, the Centers for Medicare and Medicaid Services (CMS) issued a National Coverage Determination (NCD) denying coverage for transsexual surgery as a treatment for transsexualism. This NCD was deemed invalid in 2014 by the Department of Health and Human Services, allowing local coverage determinations to adjudicate Medicare claims.
PURPOSE:
In 1981, the Centers for Medicare and Medicaid Services (CMS) issued a National Coverage Determination (NCD) denying coverage for transsexual surgery as a treatment for transsexualism. This NCD was deemed invalid in 2014 by the Department of Health and Human Services, allowing local coverage determinations to adjudicate Medicare claims. 1 Since that time, there has been a marked increase in interest in surgical procedures for sex reassignment, with plastic surgery playing a prominent role. While sex reassignment surgery (SRS) has undoubtedly become safer and more reliable over recent decades, the question remains: does SRS truly help patients with gender dysphoria over the long term? We performed a systematic review to investigate this issue.
METHODS:
The literature surrounding sex reassignment surgery is broad, diverse, and uneven. We performed a PubMed search with a focus on SRS, patient satisfaction, and outcomes. References within relevant studies, chapters, review articles, and government publications were reviewed. Studies were assessed for level of evidence, quality of study design, and specific outcomes measured.
RESULTS:
Among the over forty studies examined, the evidence is conflicting, generally of low quality, and lacking strength due to inconsistent methodology, lack of control groups, short-term follow up, small sample sizes, and/or variable outcomes. While subjective measures like patient satisfaction and quality of life are important and generally show improvement, 2 objective outcomes like psychiatric treatment, requests for surgical reversal, and mortality are vital for evaluating the overall effectiveness of SRS. One of the most robust studies examined all patients in Sweden undergoing SRS over 30 years and compared them to random population controls; it found markedly increased adjusted hazard ratios for overall mortality (2.8), particularly death from suicide (19.1), as well as cardiovascular disease (2.5) and neoplasm (2.1); suicide attempts (4.9); and psychiatric inpatient care (2.8), with the overall mortality impact becoming apparent only after 10 years of follow-up. 3 While the study did not examine the impact of SRS independently, it demonstrated that patients undergoing SRS do not return to normal population risk levels of morbidity and mortality, and that one of the most important metrics, survival, is not clearly affected until 10 years after surgery.
CONCLUSION:
Sex reassignment surgery has progressed a great deal over the last sixty years, with substantive contributions from many medical specialties, including plastic surgery, leading to more safe, functional, aesthetic, and satisfactory outcomes for patients with gender dysphoria. However, what remains to be determined is how effectively SRS treats gender dysphoria over the long term; the literature seems indeterminate at this time. CMS has not issued a NCD regarding SRS "because the clinical evidence is inconclusive for the Medicare population."
4 Plastic surgery should be at the forefront of studying and providing the evidence that the government, physicians, and our patients need.
Gender Reassignment Surgery Using the Pedicle Transverse Colon Flap for Vaginal Reconstruction: A Clinical Outcome and Sexual Function Evaluation Study
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INTRODUCTION: Vaginal reconstruction is indicated in vaginal agenesis, following pelvic tumor resection, trauma and for sexual-reassignment surgery. Different surgical options have been described for vaginal reconstruction. Herein, we present the clinical outcomes and sexual function evaluation using the pedicle transverse colon flap (TCF) for gender reassignment surgery in transgender women.
METHODS:
This is a retrospective chart review of all transgender women who underwent gender reassignment surgery using the pedicle TCF. Demographics, etiology, procedure specifics and surgical outcomes were recorded and analyzed. Sexual function was measured using the Female Sexual Function Index (FSFI) and the female genital self-image scale (FGSIS) one year after surgery.
RESULTS:
15 patients underwent gender reassignment surgery using the pedicle transverse colon flap. Average age was 20, (range: 18-32 years), average OR time was 10.1 hours; (8-12.5 hrs.). The average length and width of the flaps was 15 cm and 2.8 cm respectively. During a 12-year follow-up, two complications were reported: one patient had pain due to narrowing at the neovaginal inlet, which required re-intervention and one patient had excessive amount of secretions in the first month which subsided at the third month after surgery. The mean FSFI score was 28.6 (range 24-31). All patients achieved a normal sexual function as indicated by a FSFI score of 25 or more. For the FGSIS, the mean total score was 20.0 ± 4.5 (range: 7-28).
CONCLUSION:
The pedicle transverse colon flap is another valuable alternative method for vaginal reconstruction with promising results and minor complications.
Multiple Anastomotic Thrombus Due to Decreased Anti-Thrombin Activity during Microvascular Anastomosis -Case Report
Presenter: Takafumi Uchibori, MD, PhD Co-Authors: Keisuke Takanari, MD, PhD; Katsumi Ebisawa, MD, PhD; Miki Kanbe, MD; Yutaka Nakamura, MD; Yuzuru Kamei, MD, PhD Affiliation: Nagoya University, Nagoya INTRODUCTION: With recent advances in microsurgical instruments and technique, microvascular anastomosis has become a universal surgical technique however, thrombosis still presents in a number of cases. Tension, twisting and compression to the anastomotic site are the main causes of thrombus however disorder of the coagulation fibrinolysis system also need to be considered. To date, only few reports exist regarding thrombosis caused by disorder of coagulant system in microvascular anastomosis. Here we report our three cases in which multiple thrombus formation occurred intraoperatively caused by decrease of antithrombin (AT) activity.
CASE REPORTS:
Case 1: A 70-year-old male presenting with an esophageal and intestinal fistula after gastric tube cancer were subjected to jejunal pull-up through ante-thoracic route and vascular augmentation to the jejunal artery and vein with the internal thoracic artery and vein was performed. During the operation, arterial thromboses occurred three time and venous thromboses occurred four time. Intraoperative examination showed AT activity decrease (50 %) and AT transfusion was performed. After transfusion, arterial or venous thrombosis was not observed. The intraoperative bleeding volume was 1100ml and the operation time was 12 hours 20 minutes.
Case 2: A 77-year-old man presenting with a right hepatic artery injury during hepatectomy for hilar cholangiocarcinoma. Resection of injured artery followed by vascular anastomosis were performed however thrombosis was observed 3 times. Intraoperative blood test showed marked decreaseof AT activity (25 %) and AT transfusion was performed. Fourth arterial anastomosis was performed after AT transfusion and no further thrombosis was observed thereafter. Intraoperative bleeding volume was 403ml and operation time was 13 hours 23 minutes.
Case 3: A 78-year-old man presenting with extensive left maxillary sinus carcinoma underwent left total maxillectomy, anterior and middle skull base resection, and subsequent free rectus abdominis myocutaneous flap
